Fraunhofer Institute for Toxicology and Experimental Medicine

SOT 2020 in Anaheim

Meet us at the SOT 59th Annual Meeting and ToxExpo from March 15 to 19, 2020, at our Booth No. 754 or in our Exhibitor-Hosted Sessions!

more info

Fighting bacteria with viruses

Fraunhofer scientists have joined forces with partners in the Phage4Cure project to explore alternatives to antibiotics.

more info

Training course: In-silico toxicology

The training course In-silico toxicology will take place from June 3 to 5, 2020. Click here to register for this training course.

more info

Respiratory infections

Fraunhofer ITEM research teams are facing up to the challenges in infection research. Dr. Sabine Wronski, manager of the Working Group on Infection and Immunology, talks about this in an interview.

more info

Cluster of Excellence for Immune-Mediated Diseases CIMD

By teaming up with Fraunhofer IME, Fraunhofer IZI and other partners, we aim to advance the translation of innovative ideas and identified targets into individualized therapies for immune-mediated diseases.

more info

Replacing animal testing

Fraunhofer ITEM advances the development of new-approach methodologies. Our scientists Dr. Sylvia Escher and Dr. Tanja Hansen discussed the paradigm shift in chemical risk assessment.

more info

Gentle treatment for premature babies

Researchers at Fraunhofer ITEM are working on an intelligent inhalation system for babies with lung diseases.

more info

Chip-based cell analysis by chip cytometry

New technology at Fraunhofer ITEM enables sputum analysis by chip cytometry.

more info

Fraunhofer ITEM: News


Press Release / 3.12.2019

EU project imSAVAR

Making novel therapeutics safer: Fraunhofer ITEM participates in an EU project to develop innovative model systems for the evaluation of immunomodulatory therapeutics.

News / 17.2.2020

Keep up and accelerate innovation in biomedical engineering

Thematic forum at Fraunhofer ITEM: new impetus for biomedical engineering 

News / 31.1.2020


Two of our scientists were awarded poster prizes at the Annual Meeting of the German Center for Lung Research.


Press Release / 2.1.2020

New agents to fight multidrug-resistant germs

Scientists use viruses called bacteriophages to vanquish multidrug-resistant pathogens. 

Press Release / 4.12.2019

Fighting infections and resistances

In the iCAIR® project, Fraunhofer researchers are developing new, urgently needed agents against influenza.

News / 4.12.2019

New Publication in "Toxicology in Vitro"

"In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection"


Fraunhofer ITEM

Fraunhofer Institute for Toxicology and Experimental Medicine ITEM

Nikolai-Fuchs-Strasse 1
30625 Hannover

Phone +49 511 5350-0



International Symposium "Experimental Medicine in Lung Disease"

Twenty years of clinical research at Fraunhofer ITEM is a great opportunity to discuss current issues in clinical lung research with internationally renowned experts. Please save the Dates November 12 and 13 for our symposium "Experimental Medicine in Lung Disease – 20 years of Fraunhofer ITEM Clinical Research".
Read more


SOT 2020

We are pleased to present our most recent research on toxicological issues at this year’s Annual Meeting of the Society of Toxicology (SOT) in Anaheim, CA (USA), from March 15 to 19, 2020. Visitors are welcome to visit our booth, our Exhibitor-Hosted Sessions, and our poster presentations. Please do not hesitate to contact us in advance, if you wish to arrange a meeting.
Read more


DGPT Annual Conference 2020

The Annual Conference 2020 of the German Society of Pharmacology and Toxicology and 5th German Pharm-Tox Summit will be held in Leipzig (Germany) from March 2 to 5. Fraunhofer ITEM scientists will actively participate by contributing several presentations to the scientific program.
Read more


Liquid Biopsy Summit 2020

This year's Liquid Biopsy Summit will be held in Lisbon, Portugal, on February 20 and 21, 2020. The event will bring together the leaders in the field from pharma, biotech, Dx companies and healthcare and be the home of multi-stakeholder and pan-industry collaboration for liquid biopsy, molecular pathology and precision medicine experts. Fraunhofer ITEM scientist Christian Werno will contribute a talk to the program of the Liquid Biopsy Summit 2020.
Read more

Our services and expertise


Drug Development

From drug candidate to proof of concept


Chemical Safety and Assessment

From risk analysis towards safe products


Translational Biomedical Engineering

From idea to safe medical device


Personalized Tumor Therapy

From molecular analysis to personalized therapy

About Fraunhofer ITEM

The Fraunhofer Institute for Toxicology and Experimental Medicine ITEM is one of approximately 70 institutions of the Fraunhofer-Gesellschaft, Europe's leading organization for applied research. Protecting man from health hazards in our industrialized world and contributing to the development of novel therapeutic approaches are the aims Fraunhofer ITEM is pursuing with its contract research. With a focus on airway research, our R&D portfolio includes three thematic areas: drug development, chemical safety, and translational biomedical engineering. In addition, our scientists in Regensburg do research in the field of personalized tumor therapy.

With a staff of approximately 300 at its locations in Hannover, Braunschweig and Regensburg, the institute cooperates with industry, service providers, and public authorities in projects that drive economic development and serve the wider benefit of society.

More information about Fraunhofer ITEM